Name: Oncolytics Biotech Inc. (ONCY) Balance Sheet
Creator: FinSpry

Oncolytics Biotech Balance Sheet Analysis

Assets, liabilities, and stockholders equity in millions CAD

Income Statement Balance Sheet Cash Flow Ratios

Scale:

Scroll to see more

Balance sheet showing assets, liabilities, and shareholders' equity for Oncolytics Biotech Inc. (ONCY) - Annual data in millions CAD
Breakdown	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018
Period Ending	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020	Dec 2019	Dec 2018
Current Assets
Cash and Cash Equivalents	15.94	34.91	11.67	41.26	31.22	14.15	13.70
Short-Term Investments	0.00	0.00	20.47	0.00	0.00	0.00	0.00
Cash & Short-Term Investments	15.94	34.91	32.14	41.26	31.22	14.15	13.70
Accounts Receivable	0.07	0.02	0.03	0.87	0.09	2.07	0.05
Inventory	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Other Current Assets	1.89	3.25	1.70	2.78	2.43	0.00	0.00
Total Current Assets	18.88	38.17	35.68	44.90	33.74	18.93	14.45
Non-Current Assets
Property, Plant & Equipment (Net)	1.31	0.65	0.65	0.98	0.61	0.73	0.41
Other Non-Current Assets	0.00	0.00	1.00	0.00	0.00	0.00	0.00
Total Non-Current Assets	1.31	0.65	1.65	0.98	0.61	0.73	0.41
Total Assets	20.19	38.82	37.33	45.88	34.35	19.66	14.87
Current Liabilities
Accounts Payable	1.09	1.08	2.25	0.59	1.81	3.17	1.83
Short-Term Debt	0.28	0.00	0.00	0.00	0.00	0.00	0.00
Accrued Liabilities	3.71	2.49	1.40	1.39	0.00	0.00	0.00
Other Current Liabilities	1.62	0.53	0.08	0.41	0.66	9.36	0.06
Total Current Liabilities	6.69	4.24	3.95	2.69	2.71	12.87	2.81
Non-Current Liabilities
Long-Term Debt	0.79	0.29	0.16	0.36	0.15	0.17	0.00
Other Non-Current Liabilities	0.00	0.00	0.00	0.00	0.00	0.00	0.05
Total Non-Current Liabilities	7.52	7.02	6.89	7.09	6.88	6.90	5.86
Total Liabilities	14.20	11.26	10.83	9.78	9.59	19.77	8.67
Stockholders' Equity
Common Stock	438.19	430.91	404.04	391.35	356.82	0.00	0.00
Retained Earnings	-477.71	-446.00	-418.25	-393.42	-367.11	-344.61	-311.48
Accumulated Other Comprehensive Income	0.96	0.54	0.66	0.39	0.40	0.46	0.61
Additional Paid-in Capital	44.54	42.12	40.05	34.16	31.02	29.34	28.26
Shares Outstanding	80.02	74.42	61.33	55.04	0.00	0.00	0.00
Total Stockholders' Equity	5.98	27.56	26.50	36.10	24.75	-0.11	6.20
Total Liabilities & Equity	20.19	38.82	37.33	45.88	34.35	19.66	14.87